• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

THE PATH
TO PROOF

Best-in-class clinical trial technologies and services, generating what matters to you most: high-quality trial data

EXPLORE eCLINICAL SOLUTIONS GET IN TOUCH
older man using ecoa
woman in wheelchair using ecoa
women with bandaid in vaccine trial using ecoa
Person using smartphone
Person wearing glasses

Delivering quality clinical trial data is your job. Making it easy and reliable is ours.

You're challenged with every trial to extract clean, reliable data from patients and sites. We take the pressure off with comprehensive clinical technology, unmatched data collection and therapeutic expertise, and global support. For any trial, anywhere in the world.

33-1

SOLUTION

Experience full-featured, best-in-class eClinical solutions with zero capability gaps


32

SCIENCE

Leverage our credible scientific and technical expertise to ensure trial integrity and deliver high-quality, reliable evidence

31

SCALE

Count on our robust operational architecture and capacity to support global trials seamlessly


30

SERVICE

Receive high-quality, mature project management and dedicated support



Get there with someone who's been there

website - image - supply

With 30 years of experience, thousands of trials supported, and hundreds of drug approvals secured, Signant is the partner sponsors and CROs trust to deliver high-quality data to support trial decisions and regulatory submissions.

Early-stage protocol guidance

Leverage 50+ in-house scientists and clinicians who help shape protocol design and measurement strategy to ensure the best quality data and reliable evidence

Tailored solutions

Ensure optimal solutions with our attentive and seasoned implementation teams, who tailor their recommendations and approach to meet your protocol requirements and simplify site and patient participation

Reliable results

Partner with industry veterans who have supported clinical trials associated with 25% of novel drug approvals across FDA and EMA from 2021-2024*

*Regulatory authorization for new drugs in first indication: Novel Drug Approval (FDA) and Marketing Authorization for New Active Substance (EMA).

DISCUSS PROTOCOL

Gain ultimate control over your clinical data and clinical IP with comprehensive solutions delivered under one roof

Discover the latest developments in clinical data collection

Level up your knowledge on clinical data collection
with our always-free resources

EXPLORE THE RESOURCE HUB GET INSIGHTS FROM OUR BLOG